Tigecycline Successfully Treats One Case of Relapsed Leukemia- Drug-resistant Double Sepsis

Abstract BackgroundNowadays, tigecycline is often used in combination with other antibiotics. To the best of our knowledge, this was the first documented use tigecycline alone for drug-resistant double sepsis in a patient suffering from leukemia.. The aim of this study is to reduce unnecessary drug combinations associated with tigecycline and use antibiotics reasonably. Case presentationA 29-year-old young man was admitted to the hospital because of "limb right leg, pain for 4 years, fever, blood in the stool, and sudden disturbance of consciousness for 1 week". The patient was a relapsed patient with advanced acute leukemia, with severe perianal infection and neutrophil deficiency. At the same time, blood culture suggested Acinetobacter luffi (Imipenem resistance) and Enterococcus faecium (vancomycin resistance). Tigecycline is used alone, and conventional doses are used to achieve the effect of curing double sepsis experience..ConclusionsGenerally speaking, tigecycline is a bacteriostatic agent, doctors are used to a combination of Tigecycline and other antibiotics in fighting infections.In this case, tigecycline is used alone, and conventional doses are used to achieve the effect of curing double sepsis experience. This medical record adds to the doctor,s experience with the use of tigecycline.